Author:
Cvetkoska Aleksandra,Maček-Lebar Alenka,Trdina Peter,Miklavčič Damijan,Reberšek Matej
Abstract
AbstractTo minimize neuromuscular electrical stimulation during electroporation-based treatments, the replacement of long monophasic pulses with bursts of biphasic high-frequency pulses in the range of microseconds was suggested in order to reduce muscle contraction and pain sensation due to pulse application. This treatment modality appeared under the term high-frequency electroporation (HF-EP), which can be potentially used for some clinical applications of electroporation such as electrochemotherapy, gene electrotransfer, and tissue ablation. In cardiac tissue ablation, which utilizes irreversible electroporation, the treatment is being established as Pulsed Field Ablation. While the reduction of muscle contractions was confirmed in multiple in vivo studies, the reduction of pain sensation in humans was not confirmed yet, nor was the relationship between muscle contraction and pain sensation investigated. This is the first study in humans examining pain sensation using biphasic high-frequency electroporation pulses. Twenty-five healthy individuals were subjected to electrical stimulation of the tibialis anterior muscle with biphasic high-frequency pulses in the range of few microseconds and both, symmetric and asymmetric interphase and interpulse delays. Our results confirm that biphasic high-frequency pulses with a pulse width of 1 or 2 µs reduce muscle contraction and pain sensation as opposed to currently used longer monophasic pulses. In addition, interphase and interpulse delays play a significant role in reducing the muscle contraction and/or pain sensation. The study shows that the range of the optimal pulse parameters may be increased depending on the prerequisites of the therapy. However, further evaluation of the biphasic pulse protocols presented herein is necessary to confirm the efficiency of the newly proposed HF-EP.
Funder
Slovenian Research Agency
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. Kotnik, T., Rems, L., Tarek, M. & Miklavcic, D. Membrane electroporation and electropermeabilization: Mechanisms and models. Annu. Rev. Biophys. 48, 63–91 (2019).
2. Rubinsky, B. Irreversible electroporation in medicine. Technol. Cancer Res. Treat. 6, 255–259 (2007).
3. Aycock, K. N. & Davalos, R. V. Irreversible electroporation: Background, theory, and review of recent developments in clinical oncology. Bioelectricity 1, 214–234 (2019).
4. Batista, N. T., Polajžer, T. & Miklavčič, D. Cell death due to electroporation–a review. Bioelectrochemistry 141, 1150 (2021).
5. Yarmush, M. L., Golberg, A., Serša, G., Kotnik, T. & Miklavčič, D. Electroporation-based technologies for medicine: Principles, applications, and challenges. Annu. Rev. Biomed. Eng. 16, 295–320 (2014).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献